Organization
Alexion Pharmaceuticals, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Alexion Pharmaceuticals, Inc.
... Alexion Pharmaceuticals (Nasdaq: ALXN) today announced that management will present at Morgan Stanley's 16th ...
... this webinar, Pratap Singh, PhD, Director of Pharmacometrics and Quantitative Clinical Pharmacology, Alexion Pharmaceuticals, will present a QSP case study which assesses a lipid nanoparticle ...
... Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that the U.S. Food and Drug Administration (FDA) ...
... of experience working in the industry. He has developed business plans for Alexion Pharmaceuticals, Wyeth, Glaxo Smith Kline (GSK) and Bristol-Myers Squibb (BMS) in multiple ...
... shareholders of Washington Real Estate Investment Trust (NYSE:WRE), FirstEnergy Corporation (NYSE:FE), Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), Alaska Air Group, Inc. (NYSE:ALK), Fortune Brands Home & Security, ...
... DiSalvo, Myofibrillar MyopathyRARE Champion of Hope - Collaborations in Science and Technology: Alexion Pharmaceuticals, Rady's Children Institute for Genomic Medicine and Clinithink. Collaborators include Tom ...
... Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today announced financial results for the second quarter of 2018. ...
... If you want a free Stock Review on ALKS, ALNY, ALT, and ALXN sign up now athttps://stocktraderreport.com/registration/. On Monday, July 23, 2018, the NASDAQ Composite ...
... And some industry watchers have just the target in mind. Rare-disease specialist Alexion's name has been floating around as a potential buy, Bernstein analyst Ronny ...
Subscribe now for full coverage on Alexion Pharmaceuticals, Inc.
Start My Free Trial